SENSING-AI in Patients with Long COVID (SENSING-AI)

Adhera Health

Status: Completed

Conditions: Post-acute COVID-19 Syndrome

Treatments: Other: Review of available clinical data sources related to use cases

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT06247332

SEN-0121

Details and patient eligibility

About

The retrospective study will be used to develop an artificial intelligence model of risk stratification of physiological and psychological complications arising from the information available in the electronic medical record and first consultation report to support patients and healthcare professionals in better managing the healthcare process for patients diagnosed with long COVID.

Full description

The stratification of the risk of complications related to persistent COVID both physiological and psychological in a personalized way would optimize the cost-effectiveness model for the management of these patients. Similarly, the early detection of complications associated with persistent COVID in patients belonging to vulnerable groups would improve care times and, therefore, the patient's prognosis.

The primary objective for this study is to gather anonymized retrospective data of patients suffering from long COVID in order to contribute to the generation of the SENSING-AI cohort.

Enrollment: 103 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Legal adult
• Diagnosed of long COVID-19 in the last year
• With the presence of any of these symptoms:
• Asthenia (Tiredness)
• Dyspnea
• Shortness of breath
• Anxiety
• Stress
• Depression
• Sleep disorder

Exclusion criteria

• Attended to specialized care consultation
• Was admitted in hospital in the last year due to a problem not related to the COVID complications

Trial design

103 participants in 1 patient group

Retrospective Long COVID cases

Description:

The target population will be as balanced as possible between subjects who needed specialized care due to long COVID-19 complications (either specialized care consultations or any non-planned hospital admission) at 1 month, 3 months, 6 months and 1 year from the long COVID-19 diagnose and those who did not require such specialized care.

Treatment:

Other: Review of available clinical data sources related to use cases